OliX Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.3%.

Top 22 shareholders own 41.13% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
23.6%	Dong-Ki Lee	3,905,178	₩61.2b	0%	no data
5.7%	Mirae Asset Global Investments Co., Ltd.	942,614	₩14.8b	9.61%	0.01%
5.2%	National Pension Service	860,000	₩13.5b	0%	0.01%
2.22%	The Vanguard Group, Inc.	366,483	₩5.7b	10.2%	no data
1.06%	Kiwoom Investment Co., Ltd.	175,324	₩2.7b	0%	12.23%
1.05%	AJU IB INVESTMENT Co., Ltd.	173,402	₩2.7b	0%	2.2%
0.76%	JP Morgan Asset Management	125,670	₩2.0b	0%	no data
0.38%	Sun-Woo Hong	62,348	₩977.0m	0%	no data
0.36%	Chung-Gil Kang	60,000	₩940.2m	0%	no data
0.25%	Norges Bank Investment Management	41,211	₩645.8m	-38.4%	no data
0.24%	Shin-Yeong Park	40,000	₩626.8m	0%	no data
0.23%	PineBridge Investments LLC	37,803	₩592.4m	0%	no data
0.031%	State Street Global Advisors, Inc.	5,137	₩80.5m	-11.6%	no data
0.0073%	Yang-gyun Kim	1,200	₩18.8m	0%	no data
0.0045%	KB Asset Management Co., Ltd.	743	₩11.7m	0%	no data
0.0013%	Samsung Asset Management Company, Ltd.	217	₩3.4m	-3.13%	no data
0.00061%	Tae-Gyeong Kim	100	₩1.6m	0%	no data
0.00054%	Kiwoom Asset Management Co., Ltd.	89	₩1.4m	0%	no data
0.00053%	NH Investment & Securities Co., Ltd., Asset Management Arm	87	₩1.4m	-98.7%	no data
0.00047%	NH-Amundi Asset Management	78	₩1.2m	-7.14%	no data
0.00041%	Invesco Capital Management LLC	68	₩1.1m	0%	no data
0.00021%	Hanwha Asset Management Co. Ltd.	34	₩543.8k	0%	no data